Pharmaceutical

Ethris shares positive data with mRNA drug following new funding    

ETH47 is a type III interferon-encoding mRNA drug that could be used to treat respiratory diseases including uncontrolled asthma.

Jun 26, 2024 - 04:00
Ethris shares positive data with mRNA drug following new funding    
ETH47 is a type III interferon-encoding mRNA drug that could be used to treat respiratory diseases including uncontrolled asthma.
Read the original article

Tags:

Previous Article

Pharma packaging solutions, design and companies

Next Article

Merck KGaA abandons Phase III trial for $1.08bn head & neck cancer drug

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Proposal to protect abortion patients’ records faces pushback from Epic, UnitedHealth

Proposal to protect abortion patients’ records faces pu...

Dec 7, 2023

BMS licenses TCR-T immunotherapy therapy from Immatics

BMS licenses TCR-T immunotherapy therapy from Immatics

May 2, 2023

Opinion: The lesson biotech absolutely should not take from Silicon Valley Bank’s failure

Opinion: The lesson biotech absolutely should not take ...

Mar 22, 2023